GAM Holding’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,270
Closed -$1.59M 279
2020
Q3
$1.59M Hold
2,270
0.1% 217
2020
Q2
$1.79M Sell
2,270
-1,556
-41% -$1.17M 0.11% 208
2020
Q1
$2.28M Hold
3,826
0.15% 173
2019
Q4
$4.35M Hold
3,826
0.21% 141
2019
Q3
$4.55M Hold
3,826
0.2% 125
2019
Q2
$6.3M Hold
3,826
0.25% 104
2019
Q1
$7.8M Buy
3,826
+1,556
+69% +$2.74M 0.33% 79
2018
Q4
$2.92M Sell
2,270
-1,057
-32% -$1.62M 0.15% 165
2018
Q3
$6.29M Buy
3,327
+571
+21% +$1.18M 0.23% 123
2018
Q2
$5.6M Hold
2,756
0.19% 137
2018
Q1
$6.1M Buy
2,756
+278
+11% +$707K 0.22% 130
2017
Q4
$5.72M Sell
2,478
-564
-19% -$1.15M 0.18% 150
2017
Q3
$5.41M Buy
3,042
+657
+28% +$918K 0.23% 135
2017
Q2
$3.25M Hold
2,385
0.05% 406
2017
Q1
$2.81M Hold
2,385
0.04% 433
2016
Q4
$1.91M Buy
2,385
+501
+27% +$398K 0.03% 497
2016
Q3
$1.65M Sell
1,884
-1,883
-50% -$1.36M 0.03% 518
2016
Q2
$2.11M Buy
3,767
+1,883
+100% +$1.07M 0.03% 504
2016
Q1
$1.04M Sell
1,884
-1,382
-42% -$849K 0.02% 618
2015
Q4
$2.72M Buy
+3,266
New +$3.26M 0.04% 417
2013
Q4
Sell
-309
Closed -$108K 901
2013
Q3
$108K Buy
+309
New +$115K ﹤0.01% 1038

Other funds holding BLUE

GAM Holding's BLUE Position: Q4 2020 in Review

GAM Holding sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 2,270 shares — an estimated $1.59M sold.

GAM Holding first reported a position in BLUE in Q3 2013 and held it in 21 quarters. The position peaked at $7.8M in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • GAM Holding reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • GAM Holding sold 2,270 bluebird bio shares in Q4 2020, an estimated $1.59M.
  • GAM Holding first reported a position in bluebird bio in Q3 2013 and held it in 21 quarters.
  • GAM Holding's bluebird bio position peaked at $7.8M in Q1 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on GAM Holding's 13F filing for Q4 2020, filed 10 Feb 2021.